Research feed
Recently published diabetes studies added to Dediabetes, summarized and organized by intervention and outcome.
Sorted by publication date. Some studies may have been added to Dediabetes later.
This study investigated the effects of periodontal treatment on the risk of cerebral infarction in patients with type 2 diabetes mellitus, finding significant reductions in inflammatory markers.
The study evaluated the effects of Tirzepatide combined with either Low-Energy Ketogenic Therapy or Low-Calorie Diet on hepatic steatosis in patients with MASLD, finding significant improvements in liver parameters.
This study compared the effects of liraglutide and lifestyle counseling on metabolic outcomes in obese individuals with prediabetes or early type 2 diabetes, finding comparable improvements in key metrics.
This study investigated the impact of non-surgical periodontal treatment on glycemic control and systemic inflammation in patients with Type 2 Diabetes, finding significant improvements in HbA1c and CRP levels at 6 months.
This study evaluated the impact of scaling and root planing on glycemic control in type 2 diabetes patients, finding significant improvements in various health markers.
This study evaluated the effectiveness of tirzepatide in resolving metabolic dysfunction-associated steatohepatitis (MASH) without worsening fibrosis.
This study analyzed health-related quality of life (HRQoL) in dietary interventions for type 2 diabetes, finding improvements in both low-carbohydrate high-fat (LCHF) and high-carbohydrate low-fat (HCLF) diets.
This study evaluated the effects of ertugliflozin on liver function in patients with nonalcoholic fatty liver disease and type 2 diabetes, finding significant improvements in liver-related biomarkers.
This study investigated the impact of low-level laser therapy combined with scaling and root planing on salivary calprotectin levels in periodontitis patients with type 2 diabetes, finding significant reductions in several clinical parameters.
The study investigated the effects of combined treatment with pioglitazone and metformin on liver fat in type 2 diabetes patients, finding a significant reduction in liver fat content.
Latest Evidence
Build your workspace to keep track of the latest diabetes research.
